Cogent Biosciences (United States)
Cole is an accomplished executive with extensive commercial development, new product launch, P&L, and strategic leadership experience over a 20 plus year career in the pharmaceutical industry, with a specific focus on oncology. Before joining Cogent as Chief Commercial Officer, he served at Pfizer as the Global Franchise Lead for its Genitourinary, Lung and Breast Oncology Businesses. In this role, he oversaw the global launch and lifecycle strategy for Xtandi® + Talzenna® in mCRPC.
Basic Information
- Category: business
- Website: https://www.cogentbio.com
Documented Facts
- Inception (Wikidata): 2014 (Source 3: Wikidata Q119857276, revision 2474495950)
- Country (Wikidata; date unspecified): United States (Source 3: Wikidata Q119857276, revision 2474495950; Source 4: Wikidata label: Q30, revision 2556188301)
- Official website (Wikidata; date unspecified): https://www.cogentbio.com/ (Source 3: Wikidata Q119857276, revision 2474495950)
Evidence and Sources
- Cogent Biosciences (United States) — Official Site (official)
- Cogent Biosciences (United States) on linkedin (social)
- Wikidata Q119857276, revision 2474495950 (knowledge-base)
- Wikidata label: Q30, revision 2556188301 (knowledge-base)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Cogent Biosciences (United States).
- Canonical profile: https://brandsource.ai/brands/cogent-biosciences-united-states
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/cogent-biosciences-united-states/json-ld
- Citation profile API: https://brandsource.ai/api/brands/cogent-biosciences-united-states/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (91/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Cole is an accomplished executive with extensive commercial development, new product launch, P&L, and strategic leadership experience over a 20 plus year career in the pharmaceutical industry, with a specific focus on oncology. Before joining Cogent as Chief Commercial Officer, he served at Pfizer as the Global Franchise Lead for its Genitourinary, Lung and Breast Oncology Businesses. In this role, he oversaw the global launch and lifecycle strategy for Xtandi® + Talzenna® in mCRPC.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 3 supporting sources linked.
- 3 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.